Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
N A HeeremaF M Uckun

Abstract

Nonrandom chromosomal translocations are frequently observed in pediatric patients with acute lymphoblastic leukemia (ALL). Specific translocations, such as t(4;11) and t(9;22), identify subgroups of B-lineage ALL patients who have an increased risk of treatment failure. The current study was conducted to determine the prognostic significance of chromosomal translocations in T-lineage ALL patients. The study included 169 children with newly diagnosed T-lineage ALL enrolled between 1988 and 1995 on risk-adjusted protocols of the Children's Cancer Group (CCG) who had centrally reviewed cytogenetics data. Outcome analyses used standard life-table methods. Presenting features for the current cohort were similar to those of concurrently enrolled patients for whom cytogenetic data were not accepted on central review. The majority of patients (80.5%) were assigned to CCG protocols for high-risk ALL and 86.4% had pseudodiploid (n = 80) or normal diploid (n = 66) karyotypes; modal chromosome number was not a significant prognostic factor. Overall, 103 of 169 (61%) patients had an abnormal karyotype, including 31 with del(6q), 29 with 14q11 breakpoints, 15 with del(9p), 11 with trisomy 8, nine with 11q23 breakpoints, nine with 14q32 tran...Continue Reading

Citations

Jun 30, 2000·American Journal of Clinical Pathology·R LaiW S Etches
Oct 8, 2005·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Dale A EllisonJeffrey R Sawyer
Apr 26, 2007·British Journal of Haematology·Nicholas G GottardoUrsula R Kees
Mar 22, 2007·Annals of Hematology·Torsten HaferlachClaudia Haferlach
Sep 6, 2007·Leukemia & Lymphoma·Anne UyttebroeckChristiane De Wolf-Peeters
Dec 8, 2009·British Journal of Haematology·Birgit Burkhardt
Feb 25, 2000·Current Opinion in Oncology·C H Pui
Apr 30, 2013·Pediatric Hematology and Oncology·Eva Schmidt, Birgit Burkhardt
Oct 13, 2015·Annals of Hematology·Pauline SimonUNKNOWN Children’s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC)
Aug 24, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stuart S WinterStephen P Hunger
Jun 30, 2009·Leukemia & Lymphoma·Marcela Braga MansurMaria S Pombo-de-Oliveira
Feb 27, 2009·Current Opinion in Pediatrics·Lynda M Vrooman, Lewis B Silverman
Apr 7, 2009·British Journal of Haematology·Ulrike BacherTorsten Haferlach
Jun 1, 2011·Journal of Adolescent and Young Adult Oncology·Katherine Breitenbach, Wendy Stock
Aug 20, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimberly P DunsmoreStephen P Hunger
Oct 4, 2005·The Cancer Journal·Charles G MullighanJames R Downing
Jul 28, 2016·Nature Reviews. Cancer·Laura Belver, Adolfo Ferrando
Jul 7, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jiexian MaYanhui Xie
Jan 30, 2014·International Journal of Hematology·Joonhong ParkBin Cho
Jul 3, 2002·Leukemia·O Hrusák, A Porwit-MacDonald
Dec 2, 2014·Case Reports in Genetics·Mohamad KhawandanahMohamad Cherry
Oct 26, 2016·Genes, Chromosomes & Cancer·Kristina Karrman, Bertil Johansson
Jun 13, 2003·Hematological Oncology·Mehran Karimi, Hooman Yarmohammadi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.